List of insiders holdings for AN2 Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Leonard Braden Michael 10% Owner | 2024-08-14 20:24:00 | 0 5,749,432 | 5,749,432 | Form 4 |
Aziz Kabeer Director | 2024-12-23 18:40:38 | 8,972 2,373,500 | 2,382,472 | Form 4 |
Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 2025-02-28 19:57:57 | 2,373,500 0 | 2,373,500 | Form 13G |
Easom Eric Chief Executive Officer | 2025-02-28 16:22:36 | 536,880 1,259,882 | 1,796,762 | Form 4 |
Readnour Robin Shane Director | 2024-12-23 18:32:55 | 9,077 1,234,861 | 1,243,938 | Form 4 |
Zakrzewski Joseph S Director | 2024-12-23 18:33:29 | 135,015 405,880 | 540,895 | Form 4 |
Eizen Joshua M See Remarks | 2025-02-28 16:22:55 | 292,172 0 | 292,172 | Form 4 |
Chanda Sanjay Chief Development Officer | 2025-02-28 16:27:15 | 180,574 0 | 180,574 | Form 4 |
Day Lucy Chief Financial Officer | 2025-02-28 16:26:12 | 172,170 0 | 172,170 | Form 4 |
Prior Stephen David Chief Strategy Officer | 2025-02-28 16:19:36 | 117,313 0 | 117,313 | Form 4 |
Spigelman Melvin K Director | 2024-06-21 17:58:43 | 64,503 0 | 64,503 | Form 4 |
FitzPatrick Margaret M Director | 2024-06-21 18:18:17 | 64,503 0 | 64,503 | Form 4 |
Wong Stephanie Director | 2024-06-21 17:50:49 | 64,503 0 | 64,503 | Form 4 |
Eckburg Paul Chief Medical Officer | 2024-03-29 16:19:03 | 51,416 0 | 51,416 | Form 4/A |
Krause Kevin Michael Chief Strategy Officer | 2024-03-29 16:17:22 | 31,914 0 | 31,914 | Form 4/A |
Marks Gilbert Lynn Director | 2024-12-23 18:38:58 | 31,802 0 | 31,802 | Form 4 |
Nazak Michael Adrian Chief Accounting Officer | 2023-02-17 19:23:22 | 16,600 0 | 16,600 | Form 4 |
Martin Patricia A. Director | 2024-12-23 18:42:57 | 3,166 0 | 3,166 | Form 4 |
RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 2025-02-14 18:27:01 | 0 0 | 0 | Form 13G |